Sales drive up CogState revenues
Wednesday, 24 August, 2005
Melbourne-based neurodiagnostic specialist CogState (ASX:CGS) has reported revenues of AUD$1.5 million for the financial year ending June 30 2005, nearly three times more than the previous corresponding period, largely through sales to major pharmaceutical companies and research institutions.
The company recorded an increase in sales of its diagnostic product of 434 per cent, up from $192,094 in 2004 to $1 million in 2005.
Cogstate reported a net loss of $2.2 million and at 30 June 2005 had a cash balance of balance of $3.4 million.
Unhealthy Western diet could accelerate cognitive decline
An unhealthy Western-style diet is associated with a faster cognitive decline in people with a...
Cancer drug enters clinical trials based on a false mechanism
A cancer drug currently being tested in patients appears to have entered clinical trials based on...
Russia insists there is "no plague case" following lab worker death
Russian health authorities say there is no evidence that pneumonic plague played a part in the...
